ONEMEDNET CORPORATION Deferred Revenue
ONEMEDNET CORPORATION (ONMD) had Deferred Revenue of $683.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-14
- 2026-06-30: Deferred Revenue, Current $683.00K.
- 2026-03-31: Deferred Revenue, Current $679.00K.
- 2025-12-31: Deferred Revenue, Current $389.00K.
- 2025-09-30: Deferred Revenue, Current $770.00K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2026-06-30 | $683.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $679.00K S-1/A · filed 2026-07-08 | |
| 2025-12-31 | $389.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $770.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $512.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $503.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $561.00K S-1/A · filed 2026-07-08 | |
| 2024-09-30 | $428.00K 10-Q · filed 2024-12-17 | |
| 2024-06-30 | $519.00K 10-Q · filed 2024-12-11 | |
| 2024-03-31 | $456.00K 10-Q · filed 2024-12-05 | |
| 2023-12-31 | $254.00K 10-K · filed 2025-04-15 | $254.00K 10-K · filed 2024-04-09 |
| 2023-09-30 | $412.00K 8-K/A · filed 2024-11-22 | $393.78K 10-Q · filed 2023-11-20 |
| 2022-12-31 | $184.00K 8-K/A · filed 2024-11-22 | $183.68K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |